Octreotide treatment for sulfonylurea-induced hypoglycaemia

Peter C Veitch and Rory J Clifton-Bligh
Med J Aust 2004; 180 (10): . || doi: 10.5694/j.1326-5377.2004.tb06065.x
Published online: 17 May 2004

Peter C Veitch,* Rory J Clifton-Bligh

  • 1 Department of Aged Care and Rehabilitation Medicine
  • 2 Department of Endocrinology, Royal North Shore Hospital, Clinic 1, Level 3, Pacific Highway, St Leonards, NSW 2065.


  • 1. Veitch PC, Clifton-Bligh RJ. Long-acting sulfonylureas — long acting hypoglycaemia. Med J Aust 2004; 180: 84-85. <eMJA full text>
  • 2. McLaughlin SA, Crandall CS, McKinney PE. Octreotide: an antidote for sulfonylurea-induced hypoglycaemia. Ann Emerg Med 2000; 36: 133-138.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.